Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas
出版年份 2020 全文链接
标题
Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas
作者
关键词
-
出版物
Frontiers in Oncology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-05-22
DOI
10.3389/fonc.2020.00669
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics
- (2019) Zhen Chen et al. Nature Communications
- miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2
- (2019) Wenzheng Luo et al. LIFE SCIENCES
- Chemotherapeutic Stress Induces Transdifferentiation of Glioblastoma Cells to Endothelial Cells and Promotes Vascular Mimicry
- (2019) Shivani Baisiwala et al. Stem Cells International
- STC1 regulates glioblastoma migration and invasion via the TGF‑β/SMAD4 signaling pathway
- (2019) Yan Xiong et al. Molecular Medicine Reports
- miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme
- (2019) Kuo-Hao Ho et al. PHARMACOLOGICAL RESEARCH
- Stanniocalcin-1 augments stem-like traits of glioblastoma cells through binding and activating NOTCH1
- (2018) Yong Li et al. CANCER LETTERS
- Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response
- (2018) Sabine Hombach-Klonisch et al. PHARMACOLOGY & THERAPEUTICS
- Identification of Key Candidate Proteins and Pathways Associated with Temozolomide Resistance in Glioblastoma Based on Subcellular Proteomics and Bioinformatical Analysis
- (2018) Guo-zhong Yi et al. Biomed Research International
- Blockade of Na/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy
- (2018) Xiudong Guan et al. Cell Death & Disease
- 20(S)‐ginsenoside‐Rg3 reverses temozolomide resistance and restrains epithelial‐mesenchymal transition progression in glioblastoma
- (2018) Zheng Chen et al. CANCER SCIENCE
- Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway
- (2018) Hua-Chao Yang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells
- (2017) Huijun Zeng et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- TERT promoter mutations in telomere biology
- (2017) Barbara Heidenreich et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis
- (2017) R. H. Dahlrot et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- PomGnT1 enhances temozolomide resistance by activating epithelial-mesenchymal transition signaling in glioblastoma
- (2017) Qi Liu et al. ONCOLOGY REPORTS
- Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas
- (2016) Ming-Yang Li et al. Scientific Reports
- A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
- (2016) Hideyuki Arita et al. Acta Neuropathologica Communications
- Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide
- (2015) Khaled Messaoudi et al. DRUG DISCOVERY TODAY
- PTPRN2 and PLC 1 promote metastatic breast cancer cell migration through PI(4,5)P2-dependent actin remodeling
- (2015) C. A. Sengelaub et al. EMBO JOURNAL
- Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression
- (2015) Gloria Perazzoli et al. PLoS One
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
- (2013) Mark R. Gilbert et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 2 study of dose-intense temozolomide in recurrent glioblastoma
- (2013) A. D. Norden et al. NEURO-ONCOLOGY
- mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy
- (2013) M. Weiler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
- (2012) Wanjuan Yang et al. NUCLEIC ACIDS RESEARCH
- Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial
- (2011) Jaime Gállego Pérez-Larraya et al. JOURNAL OF CLINICAL ONCOLOGY
- NKX3.1 Activates Expression of Insulin-like Growth Factor Binding Protein-3 to Mediate Insulin-like Growth Factor-I Signaling and Cell Proliferation
- (2009) E. Muhlbradt et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search